Clene Inc. Clene Inc.
  • About Us
    • Leadership
    • Board of Directors
  • Science
  • Pipeline
    • About CNM-Au8
  • Patients
    • EAP
  • Investors
    • Overview
    • Press
    • Scientific Posters & Presentations
    • Events
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Investor Resources
  • Contact
Clene Inc. Clene Inc.
  • About Us
    • Leadership
    • Board of Directors
  • Science
  • Pipeline
    • About CNM-Au8
  • Patients
    • EAP
  • Investors
    • Overview
    • Press
    • Scientific Posters & Presentations
    • Events
    • Corporate Governance
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Investor Resources
  • Contact

Reed N Wilcox

Reed Wilcox is the President of Southern Virginia University. Reed co-founded Clene Nanomedicine. Prior to Clene Nanomedicine, President Wilcox was co-founder and senior managing director of General Resonance. Earlier, Reed... read more →
  • November 2, 2021
  • Dianna Jensen

Jonathon Gay

Mr. Gay is a Managing Partner at Kensington-SV Global Innovations LP (KSV), a growth stage investment firm which he co-founded in 2018. Prior to joining KSV, Mr. Gay was Managing... read more →
  • November 2, 2021
  • Dianna Jensen

Vallerie V. McLaughlin, MD

Vallerie V. McLaughlin, MD, is the Kim A. Eagle MD Endowed Professor of Cardiovascular Medicine, and Director of the Pulmonary Hypertension Program at the University of Michigan in Ann Arbor.... read more →
  • November 2, 2021
  • Dianna Jensen

John Stevens, MD

John Stevens, MD, currently serves as the chairman and CEO of Heartflow, Inc, a provider of noninvasive cardiovascular imaging technology, and as the managing partner of Headwaters Capital Partners. John... read more →
  • November 2, 2021
  • Dianna Jensen

Shalom “Shal” Jacobovitz

Shalom “Shal” Jacobovitz is the chief executive officer of CIVI Bio, a privately held biopharmaceutical, and the former CEO of the American College of Cardiology. In this role at the... read more →
  • November 2, 2021
  • Dianna Jensen

Chidozie Ugwumba

Chidozie Ugwumba serves as Managing Partner of SymBiosis, a venture capital firm focused on investments in biotherapeutics. At SymBiosis, Mr. Ugwumba leads sourcing, due diligence, and execution of investments, and... read more →
  • November 2, 2021
  • Dianna Jensen

Alison Mosca

Alison Mosca is a Managing Director & CEO of Kensington Capital Holdings. Prior to founding Kensington Capital Holdings, Alison built a multi-family office within Audax Group, a leading middle market... read more →
  • November 2, 2021
  • Dianna Jensen

Rob Etherington

Mr. Etherington brings nearly 30 years of sales, marketing and leadership experience in the pharmaceutical industry to Clene. Prior to joining Clene as CEO, Mr. Etherington worked for Actelion Pharmaceuticals,... read more →
  • November 2, 2021
  • Dianna Jensen

David J. Matlin

Mr. Matlin was the Chief Executive Office of MatlinPatterson Global Advisers LLC, a global private equity firm, which he co-founded in 2002. David was a former Managing Director at Credit... read more →
  • November 2, 2021
  • Dianna Jensen

1-801-676-9695
info@CleneNanomedicine.com

Headquarters and Development

6550 South Millrock Drive, Suite G50
Salt Lake City, Utah 84121

Manufacturing, R&D

500 Principio Parkway West Suite 400
North East, Maryland 21901

Clene Nanomedicine, Inc. is a wholly owned subsidiary of Clene Inc. | © 2022 Clene Nanomedicine Inc. - All rights reserved